Dave Helsel - 20 Oct 2021 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role: SVP Global Operations and R&D
Signature: /s/ Richard C. Rosenzweig, Attorney in Fact
Issuer symbol: ANGO
Transactions as of: 20 Oct 2021
Net transactions value: -$97,727
Form type: 4
Filing time: 21 Oct 2021, 16:50:13 UTC
Previous filing: 18 Aug 2021
Next filing: 02 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANGO	Common Stock	Sale	$97,727	-3,494	-12%	$27.97	26,387	20 Oct 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.95 to $28.05, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.95 to $28.05, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.